These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23652254

  • 1. An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.
    Safigholi H, Sardari D, Karimi Jashni S, Mahdavi SR, Meigooni AS.
    J Appl Clin Med Phys; 2013 May 06; 14(3):4226. PubMed ID: 23652254
    [Abstract] [Full Text] [Related]

  • 2. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Med Phys; 2013 Mar 06; 40(3):031717. PubMed ID: 23464312
    [Abstract] [Full Text] [Related]

  • 3. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Brachytherapy; 2014 Mar 06; 13(6):603-10. PubMed ID: 24913435
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for 125 I prostate implants.
    Assam I, Vijande J, Ballester F, Pérez-Calatayud J, Poppe B, Siebert FA.
    Med Phys; 2022 Sep 06; 49(9):6195-6208. PubMed ID: 35925023
    [Abstract] [Full Text] [Related]

  • 5. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials.
    Zehtabian M, Sina S, Faghihi R, Meigooni A.
    J Appl Clin Med Phys; 2013 May 06; 14(3):4228. PubMed ID: 23652255
    [Abstract] [Full Text] [Related]

  • 6. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
    Afsharpour H, D'Amours M, Coté B, Carrier JF, Verhaegen F, Beaulieu L.
    Med Phys; 2008 Aug 06; 35(8):3671-81. PubMed ID: 18777927
    [Abstract] [Full Text] [Related]

  • 7. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O, Williamson JF, Todor D.
    Med Phys; 2005 Aug 06; 32(8):2557-66. PubMed ID: 16193786
    [Abstract] [Full Text] [Related]

  • 8. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F, Carlsson Tedgren Å, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L.
    Med Phys; 2015 Jun 06; 42(6):3048-61. PubMed ID: 26127057
    [Abstract] [Full Text] [Related]

  • 9. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C, Reniers B, Bertrand MJ, Poon E, Carrier JF, Keller BM, Pignol JP, Beaulieu L, Verhaegen F.
    Med Phys; 2009 May 06; 36(5):1848-58. PubMed ID: 19544804
    [Abstract] [Full Text] [Related]

  • 10. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA, Yang Y, Rivard MJ.
    Med Phys; 2011 Jun 06; 38(6):2957-63. PubMed ID: 21815369
    [Abstract] [Full Text] [Related]

  • 11. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S, Nedaie HA, Sadeghi M, Pourbeigy H, Shahzadi S, Zehtabian M, Hasani M, Meigooni AS.
    J Appl Clin Med Phys; 2016 Jul 08; 17(4):430-441. PubMed ID: 27455485
    [Abstract] [Full Text] [Related]

  • 12. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy.
    Ma Y, Vijande J, Ballester F, Tedgren ÅC, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L.
    Med Phys; 2017 Nov 08; 44(11):5961-5976. PubMed ID: 28722180
    [Abstract] [Full Text] [Related]

  • 13. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ, García-Pareja S, Cenizo E, Mateo B, Bodineau C, Galán P.
    Phys Med; 2010 Nov 08; 26(3):132-9. PubMed ID: 20034828
    [Abstract] [Full Text] [Related]

  • 14. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G, Papagiannis P, Angelopoulos A, Karaiskos P, Georgiou E, Baltas D.
    Med Phys; 2006 Dec 08; 33(12):4583-9. PubMed ID: 17278810
    [Abstract] [Full Text] [Related]

  • 15. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E, Verhaegen F.
    Med Phys; 2009 Sep 08; 36(9):3982-94. PubMed ID: 19810471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
    Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ.
    J Appl Clin Med Phys; 2015 Sep 08; 16(5):62–75. PubMed ID: 26699290
    [Abstract] [Full Text] [Related]

  • 20. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
    Mobit P, Badragan I.
    Phys Med Biol; 2004 Jul 21; 49(14):3171-8. PubMed ID: 15357190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.